- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Dr Reddys unveils Methylphenidate Hydrochloride ER Tablets in US
Concerta is indicated to treat attention deficit hyperactivity disorder(ADHD).
Hyderabad: Dr. Reddys Laboratories Ltd. on Thursday announced the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, a therapeutic equivalent generic version of Concerta, in various strengths, in the USA market.The drug was approved by the U.S. Food and Drug Administration (USFDA), a press release from the drug maker said.Concerta is indicated to treat attention...
Hyderabad: Dr. Reddys Laboratories Ltd. on Thursday announced the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, a therapeutic equivalent generic version of Concerta, in various strengths, in the USA market.
The drug was approved by the U.S. Food and Drug Administration (USFDA), a press release from the drug maker said.
Concerta is indicated to treat attention deficit hyperactivity disorder (ADHD).
Read also: Dr Reddys launches generic version of Cuprimine Capsules in US
Dr. Reddys Methylphenidate Hydrochloride Extended- Release Tablets, USP are available in strengths of 18 mg, 27 mg, 36 mg, and 54 mg tablets in bottle count sizes of 100, it said.
Read also: Dr Reddys enters hospital nutrition segment with launch of Celevida Maxx in India
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751